Xiaohong Han
Shandong University(CN)Peking University(CN)Peking University Cancer Hospital(CN)Qilu Hospital of Shandong University(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, Immunotherapy and Immune Responses, Lymphoma Diagnosis and Treatment, Glycosylation and Glycoproteins Research
Most-Cited Works
- → First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study(2017)336 cited
- → Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study(2015)201 cited
- → Disturbed Gut-Liver axis indicating oral exposure to polystyrene microplastic potentially increases the risk of insulin resistance(2022)192 cited
- → Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer(2008)158 cited
- → Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma(2007)122 cited
- → FASL –844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer